Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV).

Isakov, Vasily

Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV). [electronic resource] - European journal of gastroenterology & hepatology 09 2018 - 1073-1076 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study

1473-5687

10.1097/MEG.0000000000001166 doi


2-Naphthylamine
Adult
Aged
Anilides--adverse effects
Antiviral Agents--adverse effects
Carbamates--adverse effects
Cyclopropanes
Drug Combinations
Drug Therapy, Combination
Female
Genotype
Hepacivirus--drug effects
Hepatitis C, Chronic--complications
Humans
Lactams, Macrocyclic
Liver Cirrhosis--diagnosis
Macrocyclic Compounds--adverse effects
Male
Middle Aged
Proline--analogs & derivatives
Republic of Belarus
Ribavirin--adverse effects
Ritonavir--adverse effects
Russia
Sulfonamides--adverse effects
Sustained Virologic Response
Time Factors
Treatment Outcome
Uracil--adverse effects
Valine